Zhong Zhong

Company: Ovid Therapeutics

Job title: Chief Scientific Officer

Seminars:

KCC2 Direct Activators to Modulate Neuronal Hyperexcitation in Psychosis 10:00 am

Transforming the treatment landscape for neurological disorders Reviewing a novel target which offers a promising new therapeutic avenue for neuropsychiatric, neurodevelopmental and neurodegenerative disordersRead more

day: Day Two